GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT) » Definitions » Ending Cash Position

Sartorius AG (XTER:SRT) Ending Cash Position : €1,103 Mil (As of Mar. 2024)


View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG Ending Cash Position?

Sartorius AG's Ending Cash Position for the quarter that ended in Mar. 2024 was €1,103 Mil.

Sartorius AG's quarterly Ending Cash Position increased from Sep. 2023 (€294 Mil) to Dec. 2023 (€379 Mil) and increased from Dec. 2023 (€379 Mil) to Mar. 2024 (€1,103 Mil).

Sartorius AG's annual Ending Cash Position declined from Dec. 2021 (€343 Mil) to Dec. 2022 (€166 Mil) but then increased from Dec. 2022 (€166 Mil) to Dec. 2023 (€379 Mil).


Sartorius AG Ending Cash Position Historical Data

The historical data trend for Sartorius AG's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Ending Cash Position Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.44 203.44 342.80 165.90 379.20

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 152.30 162.20 293.90 379.20 1,102.80

Sartorius AG Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sartorius AG's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=165.9+213.3
=379

Sartorius AG's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=379.2+723.6
=1,103


Sartorius AG Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG (XTER:SRT) Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.